Search

everythinglearnresearchcommunity

for

Search:↓

A quick and simple method was created to identify minoxidil in hair-growth products using micellar electrokinetic capillary chromatography.

People with early-onset hair loss have higher risk of heart issues, so early screening is important.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

The combined Selencin treatment effectively reduces hair loss and improves hair health after COVID-19.

Biosimilars lower costs but don't significantly improve access.

COVID-19 and its vaccines can cause hair loss, which is not serious and can improve with psychological support.

The COVID-19 pandemic has caused a 57% increase in interest in facial cosmetic procedures, leading to calls for better industry regulation and professional standards.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Testosterone may both worsen and protect against COVID-19 effects in men.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

P-3074 effectively blocks scalp DHT better than oral finasteride.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

COVID-19 may increase hair loss, and Nourkrin® could help treat it.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Minoxidil promotes hair growth by penetrating skin, with ethanol-containing formulas working best.

Artificial sebum L closely mimics human sebum for drug delivery research.

Oral minoxidil helps hair growth, is cost-effective, and mostly well-tolerated.

Nanoparticles effectively deliver water-insoluble drugs to hair follicles, stimulating hair growth without irritating the skin.

Dog hair grows back in about 14 weeks after being clipped for surgery, and the season doesn't really affect this growth rate.

A method was created in 2005 to identify minoxidil, a hair growth ingredient, in products using two types of capillary zone electrophoresis, and it found that most products had about 2% minoxidil.

Dupilumab for skin problems might reactivate hair loss in some patients.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.